CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 7, 2003--Biogen, Inc. (NASDAQ: BGEN - News) announced today that its special meeting of stockholders regarding their proposed merger with IDEC Pharmaceuticals Corporation (NASDAQ: IDPH - News) will be webcast live on November 12, 2003. The live webcast begins at 11:30 am (ET) and is accessible through Biogen's homepage, www.Biogen.com. About Biogen
Biogen is the world's oldest independent biotechnology company and a leader in biologics research, development and manufacturing. A pioneer in leading edge research in immunology, neurobiology and oncology, Biogen brings novel therapies to improve patients' lives around the world through its global marketing capabilities. For press releases and additional information about the company, please visit http://www.biogen.com.
Biogen, Inc. Rob Jacobson, 617-679-3710 Rob_Jacobson@Biogen.com
Source: Biogen, Inc.